Catabasis Pharmaceuticals, Inc. To Present At International Congress Of The World Muscle Society

Catabasis Pharmaceuticals, Inc., a clinical stage drug development company built on a pathway pharmacology technology platform, today announced that CAT-1004, the Company’s development candidate for the treatment of Duchenne muscular dystrophy (DMD), will be featured in a poster presentation at the upcoming International Congress of the World Muscle Society. The International Congress of the World Muscle Society will be held October 7-11, 2014, in Berlin, Germany.

Help employers find you! Check out all the jobs and post your resume.